Titles listed in order of publication—
January/February 2003
Page Title
1 Quantitative Determination of the Hydrolysis Products of Nitrogen Mustards in Human Urine by Liquid Chromatography–Electrospray Ionization Tandem Mass Spectrometry
7 A General Unknown Screening Procedure for Drugs and Toxic Compounds in Serum Using Liquid Chromatography– Electrospray-Single Quadrupole Mass Spectrometry
15 Direct Screening of Urine for MDMA and MDA by Liquid Chromatography–Tandem Mass Spectrometry
20 Interindividual Dose/Concentration Relationship for Methadone in Hair
24 A Selective and Sensitive Method for Quantitation of Lysergic Acid Diethylamide (LSD) in Whole Blood by Gas Chromatography–Ion Trap Tandem Mass Spectrometry
30 LC–MS Analysis of Serotonergic Drugs
36 Determination of Chromate Adulteration of Human Urine by Automated Colorimetric and Capillary Ion Electrophoretic Analyses
40 TECHNICAL NOTE: A Study of Urinary Endogenous Gamma-Hydroxybutyrate (GHB) Levels
43 TECHNICAL NOTE: An Improved HPLC Analysis of the Metabolite Furoic Acid in the Urine of Workers Occupationally Exposed to Furfural
47 CASE REPORT: Analysis of Flecainide and Two Metabolites in Biological Specimens by HPLC: Application to a Fatal Intoxication
53 CASE REPORT: Urinary Concentrations of Morphine and Codeine After Consumption of Poppy Seeds

March 2003

Page Title
57 Oxycodone Involvement in Drug Abuse Deaths: A DAWN-Based Classification Scheme Applied to an Oxycodone Postmortem Database Containing Over 1000 Cases
68 Amphetamine Concentrations in Human Urine following Single-Dose Administration of the Calcium Antagonist Prenylamine—Studies Using Fluorescence Polarization Immunoassay (FPIA) and GC–MS
74 Analysis of Polychlorinated Biphenyl Residues in Human Plasma by Gas Chromatography–Mass Spectrometry
78 Development of a Rapid and Sensitive Method for the Quantitation of Amphetamines in Human Plasma and Oral Fluid by LC–MS–MS
88 HPLC–MS for the Determination of Sildenafil Citrate (Viagra‚) in Biological Fluids. Application to the Salivary Excretion of Sildenafil after Oral Intake
95 Determination of Methamphetamine and Its Metabolites Incorporated in Hair by Column-Switching Liquid Chromatography–Mass Spectrometry
103 Enzyme Immunoassay Validation for the Detection of Buprenorphine in Urine
106 TECHNICAL NOTE: Quantitation of 11-nor-D9 Tetrahydrocannabinol-9-carboxylic Acid with GC–MS in Urine Collected for Doping Analysis
110 CASE REPORT: Tissue Distribution of Xylazine in a Suicide by Hanging
113 CASE REPORT: Fatal Acute Poisoning by Bentazon
118 CASE REPORT: Simultaneous Determination of Carisoprodol and Acetaminophen in an Attempted Suicide by Liquid Chromatography–Mass Spectrometry with Electrospray Ionization
123 LETTER TO THE EDITOR: False-Positive RIA for Methamphetamine Following Ingestion of an Ephedra-Derived Herbal Product

April 2003

Page Title
125 Cocaine, Benzoylecgonine, Amphetamine, and N-Acetylamphetamine Binding to Melanin Subtypes
135 Quantitative Analysis of Desmethylselegiline, Methamphetamine, and Amphetamine in Hair and Plasma from Parkinson Patients on Long-Term Selegiline Medication
142 Procainamide and Quinidine Inhibition of the Human Hepatic Degradation of Meperidine In Vitro
145 TECHNICAL NOTE: Distribution of Butalbital in Postmortem Tissues and Fluids from Non-Overdose Cases
149 TECHNICAL NOTE: Ofloxacin as a Reference Marker in Hair of Various Colors
156 TECHNICAL NOTE: 1H NMR Spectroscopy and GC–MS Analysis of a-Chloralose. Application to Two Poisoning Cases
162 CASE REPORT: Determination of the Herbicide Glyphosate and its Metabolite in Biological Specimens by Gas Chromatography–Mass Spectrometry. A Case of Poisoning by Roundup‚ Herbicide
167 LETTER TO THE EDITOR: Time-Adjusted Urine/Blood Ratios of Ethanol in Drinking Drivers
169 LETTER TO THE EDITOR: Comment on Oral Fluid Testing for Drugs of Abuse: Positive Prevalence Rates by Intercept‰ Immunoassay Screening and GC–MS–MS Confirmation and Suggested Cutoff Concentrations
173 LETTER TO THE EDITOR: Comment on Determination of Glycols in Biological Specimens by Gas Chromatography–Mass Spectrometry

May/June 2003

Page Title
205 Evaluation of Immunochemical Drug Screening of Whole Blood Samples. A Retrospective Optimization of Cutoff Levels after Confirmation-Analysis on GC–MS and HPLC–DAD
213 Screening of Clostebol and its Metabolites in Bovine Urine with ELISA and Comparison with GC–MS Results in an Interlaboratory Study
221 Acute Nitrobenzene Poisoning with Severe Associated Methemoglobinemia: Identification in Whole Blood by GC–FID and GC–MS
226 Screening for Basic Drugs in 2-mL Urine Samples by Dual-Plate Overpressured Layer Chromatography and Comparison with Gas Chromatography–Mass Spectrometry
233 Selectivity of Substance Identification by HPLC–DAD in Toxicological Analysis Using a UV Spectra Library of 2682 Compounds
243 TECHNICAL NOTE: Postmortem Toxicology of Carbamazepine
249 TECHNICAL NOTE: The Development and Application of a Gas Chromatography–Mass Spectrometric (GC–MS) Assay to Determine the Presence of 2-Oxo-3-Hydroxy-LSD in Urine
253 CASE REPORT: Three Fatal Cases of PMA and PMMA Poisoning in Denmark
257 CASE REPORT: An Unusual Case of Death: Suffocation Caused by Leaves of Common Ivy (Hedera helix). Detection of Hederacoside C, a-Hederin, and Hederagenin by LC–EI/MS–MS

July/August 2003

Page Title
265 Comparison and Evaluation of DRI‚ Methamphetamine, DRI Ecstasy, Abuscreen‚ ONLINE Amphetamine, and a Modified Abuscreen ONLINE Amphetamine Screening Immunoassays for the Detection of Amphetamine (AMP), Methamphetamine (MTH), 3,4-Methylenedioxyamphetamine (MDA), and 3,4-Methylenedioxymethamphetamie (MDMA) in Human Urine
270 Quantitation of Cocaine and Its Major Metabolites in Human Saliva Using Gas Chromatography–Positive Chemical Ionization-Mass Spectrometry (GC–PCI-MS)
275 Direct and Rapid Determination of Baclofen (Lioresal‚) and Carisoprodol (Soma‚) in Bovine Serum by Liquid Chromatography–Mass Spectrometry
284 Quantitative Detection of Nine Phthalate Metabolites in Human Serum Using Reversed-Phase High-Performance Liquid Chromatography–Electrospray Ionization-Tandem Mass Spectrometry
290 Distribution of Serum Paraoxon Hydrolyzing Activity in a Large Spanish Population Using a Routine Automized Method in Clinical Laboratory
294 Usefulness of Sweat Testing for the Detection of MDMA after a Single-Dose Administration
304 Simultaneous Plasma Lamotrigine Analysis with Carbamazepine, Carbamazepine 10,11 Epoxide, Primidone, Phenytoin, Phenobarbital, and PEMA by Micellar Electrokinetic Capillary Chromatography (MECC)
309 TECHNICAL NOTE: Direct Analysis of Plasticizers in Aqueous Samples by Atmospheric Pressure Chemical Ionization-Tandem Mass Spectrometry (APCI-MS–MS)
313 CASE REPORT: Foxy, a Designer Tryptamine Hallucinogen
318 CASE REPORT: Fatality Due To Combined Use of the Designer Drugs MDMA and PMA: A Distribution Study
323 CASE REPORT: Fatal Acute Topiramate Toxicity

September 2003

Page Title
325 Large-Volume Injection Gas Chromatography–Mass Spectrometry for Automated Broad-Spectrum Drug Screening in Horse Urine
332 Methadone and Metabolite Urine Concentrations in Patients Maintained on Methadone
342 An Enzyme-Linked Immunosorbent Assay (ELISA) for Methylphenidate (Ritalin®) in Urine
346 Tentative Identification of Novel Oxycodone Metabolites in Human Urine
353 A Comparative Solid-Phase Extraction Study for the Simultaneous Determination of Fluoxetine, Amitriptyline, Nortriptyline, Trimipramine, Maprotiline, Clomipramine, and Trazodone in Whole Blood by Capillary Gas–Liquid Chromatography with Nitrogen-Phosphorus Detection
359 Ephedrines in Over-the Counter Cold Medicines and Urine Specimens Collected during Sport Competitions
366 TECHINICAL NOTE: One-Step Immunoassay for Acetaminophen and Salicylate in Serum, Plasma, and Whole Blood
372 TECHNICAL NOTE: Use of Biosensors to Screen Urine Samples for Potentially Toxic Chemicals
377 TECHNICAL NOTE: Determination of Clofazimine in Leprosy Patients by High-Performance Liquid Chromatography
381 CASE REPORT: The Analysis and Distribution of Mescaline in Postmortem Tissues
383 LETTER TO THE EDITOR: Prediction of Impairment from Urine Benzoylecgonine Concentrations

October 2003

Page Title
407 Cozart“ Rapiscan Oral Fluid Drug Testing System: An Evaluation of Sensitivity, Specificity, and Efficiency for Cocaine Detection Compared with ELISA and GC–MS following Controlled Cocaine Administration
412 Opiate Recidivism in a Drug-Treatment Program: Comparison of Hair and Urine Data
429 An Evaluation of Rapid Point-of-Collection Oral Fluid Drug Testing Devices
440 A Liquid Chromatographic–Tandem Mass Spectrometric Method for the Analysis of Serotonin and Related Indoles in Human Whole Blood
445 Stability of Plasma Gamma-Hydroxybutyrate Determined by Gas Chromatography–Positive Ion Chemical Ionization-Mass Spectrometry
449 The Determination of Morphine in Urine and Oral Fluid Following Ingestion of Poppy Seeds
453 Occupational Cocaine Exposure of Crime Laboratory Personnel Preparing Training Aids for a Military Working Dog Program
464 Analysis of Buprenorphine, Norbuprenorphine, and Their Glucuronides in Urine by Liquid Chromatography–Mass Spectrometry
471 Performance characteristics of Selected Immunoassays for Preliminary Test of 3,4-Methylenedioxymethamphetamine, Methamphetamine, and Related Drugs in Urine Specimen
479 Metabolic Profile of Amphetamine and Methamphetamine Following Administration of the Drug Famprofazone
485 Amphetamine Enantiomer Excretion Profile Following Administration of Adderall
493 Postmortem Identification and Quantitation of 2,5-Dimethoxy-4-n-propylthiophenethylamine Using GC–MSD and GC–NPD
499 Fentanyl Use, Misuse, and Abuse: A Summary of 23 Postmortem Cases
505 Development of a Rapid and Sensitive Method for the Quantitation of Benzodiazepines in Calliphora vicina Larvae and Puparia by LC–MS–MS
513 Analysis of Fentanyl and Norfentanyl in Human Plasma by Liquid Chromatography–Tandem Mass Spectrometry Using Electrospray Ionization
520 Caffeine Content of Specialty Coffees
523 Fatal Cold Medication Intoxication in an Infant
527 CASE REPORT: Buprenorphine in Drug-Facilitated Sexual Abuse: A Fatal Case Involving a 14-Year-Old Boy
530 Letter to the Editor: Evaluation of a Solid-Phase Extraction Method for Codeine and Morphine in Urine Using Cerex Polycrom‰ Clin II Columns and the Speedisk‰ 48 Pressure Processor at a High Throughput Forensic Drug-Testing Laboratory

November/December 2003

Page Title
533 REVIEW: Mechanisms Underlying Postmortem Redistribution of Drugs: A Review
545 The Effect of Hair Color on the Incorporation of Codeine into Human Hair
552 Concentrations and Ratios of Amphetamine, Methamphetamine, MDA, MDMA, and MDEA Enantiomers Determined in Plasma Samples from Clinical Toxicology and Driving Under the Influence of Drugs Cases by GC–NICI-MS
560 Piperazine-Derived Designer Drug 1-(3-Chlorophenyl)piperazine (mCPP): GC–MS Studies on its Metabolism and its Toxicological Detection in Rat Urine Including Analytical Differentiation from its Precursor Drugs Trazodone and Nefazodone
569 Quantitative Identification of Atrazine and its Chlorinated Metabolites in Plasma
574 Determination of Endogenous Levels of GHB in Human Hair. Are their Possibilities for Identification of GHB Administration through Hair Analysis in Cases of Drug-Facilitated Sexual Assault?
581 Validation of the Cozart Microplate ELISA for Detection of Opiates in Hair
587 TECHNICAL NOTE: Performance of a Microtiter Plate ELISA for Screening of Postmortem Blood for Cocaine and Metabolites
592 CASE REPORT: Analysis of Metformin in Antemortem Serum and Postmortem Specimens by a Novel HPLC Method and Application to an Intoxication Case
595 CASE REPORT: Fatal Propafenone Overdoses: Case Reports and Review of the Literature
600 LETTER TO THE EDITOR: Succinylmonocholine Identified in Negative Control Tissues

| Home | Subscribe | Current Issue | Back Issues | Search | Advertise | Other Publications |